Cost-Utility Analysis of Rosuvastatin (20 mg) to Prevent Cardiovascular Diseases in Iran
Background: Cardiovascular diseases are a main cause of disease burden in developing and developed countries. This study aimed to evaluate the cost-utility of rosuvastatin 20 mg in contrast with no intervention for the prevention of cardiovascular disease in Iran. Materials and Methods: The costs an...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Col·lecció: | Advanced Biomedical Research |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/abr.abr_208_22 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|